Published in Infect Immun on November 01, 2003
The PlcR virulence regulon of Bacillus cereus. PLoS One (2008) 1.89
Genome engineering in Bacillus anthracis using Cre recombinase. Infect Immun (2006) 1.74
A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins. Protein Expr Purif (2011) 1.21
Codon-optimized fluorescent proteins designed for expression in low-GC gram-positive bacteria. Appl Environ Microbiol (2009) 1.19
Markerless multiple-gene-deletion system for Streptococcus mutans. Appl Environ Microbiol (2008) 1.14
Toxin production in a rare and genetically remote cluster of strains of the Bacillus cereus group. BMC Microbiol (2007) 1.11
Barcoding bacterial cells: A SERS based methodology for pathogen identification. J Raman Spectrosc (2008) 1.09
Specificity and polymorphism of the PlcR-PapR quorum-sensing system in the Bacillus cereus group. J Bacteriol (2005) 1.09
A new minimal replicon of Bacillus anthracis plasmid pXO1. J Bacteriol (2009) 1.08
Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection. Am J Respir Crit Care Med (2011) 1.08
A spontaneous translational fusion of Bacillus cereus PlcR and PapR activates transcription of PlcR-dependent genes in Bacillus anthracis via binding with a specific palindromic sequence. Infect Immun (2004) 1.03
Bacillus anthracis phospholipases C facilitate macrophage-associated growth and contribute to virulence in a murine model of inhalation anthrax. Infect Immun (2006) 1.00
Plasmid-encoded regulator of extracellular proteases in Bacillus anthracis. J Bacteriol (2005) 0.97
Silica induces macrophage cytokines through phosphatidylcholine-specific phospholipase C with hydrogen peroxide. Am J Respir Cell Mol Biol (2006) 0.90
Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis. Eur J Clin Microbiol Infect Dis (2013) 0.89
plcR papR-independent expression of anthrolysin O by Bacillus anthracis. J Bacteriol (2006) 0.88
Concerted action of sphingomyelinase and non-hemolytic enterotoxin in pathogenic Bacillus cereus. PLoS One (2013) 0.87
PapR peptide maturation: role of the NprB protease in Bacillus cereus 569 PlcR/PapR global gene regulation. FEMS Immunol Med Microbiol (2009) 0.86
The Bacillus cereus Hbl and Nhe tripartite enterotoxin components assemble sequentially on the surface of target cells and are not interchangeable. PLoS One (2013) 0.85
Activation of the latent PlcR regulon in Bacillus anthracis. Microbiology (2010) 0.84
Identification of three noncontiguous regions on Bacillus anthracis plasmid pXO1 that are important for its maintenance. J Bacteriol (2014) 0.82
Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA. J Immunol (2012) 0.82
A computational module assembled from different protease family motifs identifies PI PLC from Bacillus cereus as a putative prolyl peptidase with a serine protease scaffold. PLoS One (2013) 0.80
Whole genome sequencing of phage resistant Bacillus anthracis mutants reveals an essential role for cell surface anchoring protein CsaB in phage AP50c adsorption. Virol J (2012) 0.80
Genetic evidence for the involvement of the S-layer protein gene sap and the sporulation genes spo0A, spo0B, and spo0F in Phage AP50c infection of Bacillus anthracis. J Bacteriol (2013) 0.79
The IntXO-PSL Recombination System Is a Key Component of the Second Maintenance System for Bacillus anthracis Plasmid pXO1. J Bacteriol (2016) 0.78
Bacterial Sphingomyelinases and Phospholipases as Virulence Factors. Microbiol Mol Biol Rev (2016) 0.76
In vivo characterization of an Hfq protein encoded by the Bacillus anthracis virulence plasmid pXO1. BMC Microbiol (2017) 0.75
Classification of Bacillus and Brevibacillus species using rapid analysis of lipids by mass spectrometry. Anal Bioanal Chem (2016) 0.75
Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J Bacteriol (2000) 15.34
Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis. Science (2002) 9.83
Demonstration of a capsule plasmid in Bacillus anthracis. Infect Immun (1985) 8.46
A vector for systematic gene inactivation in Bacillus subtilis. Microbiology (1998) 8.00
Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis--one species on the basis of genetic evidence. Appl Environ Microbiol (2000) 7.87
Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J Bacteriol (1999) 4.50
Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans-acting element activate transcription from one of two promoters. J Bacteriol (1994) 3.98
PlcR is a pleiotropic regulator of extracellular virulence factor gene expression in Bacillus thuringiensis. Mol Microbiol (1999) 3.43
Regulation, replication, and integration functions of the Vibrio cholerae CTXphi are encoded by region RS2. Mol Microbiol (1997) 3.22
Mating system for transfer of plasmids among Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. J Bacteriol (1985) 3.09
Fluorescent Amplified Fragment Length Polymorphism Analysis of Norwegian Bacillus cereus and Bacillus thuringiensis Soil Isolates. Appl Environ Microbiol (2001) 2.85
Cloning and sequencing of the gene encoding the phosphatidylcholine-preferring phospholipase C of Bacillus cereus. Gene (1988) 2.74
A cell-cell signaling peptide activates the PlcR virulence regulon in bacteria of the Bacillus cereus group. EMBO J (2002) 2.66
Immunization studies with attenuated strains of Bacillus anthracis. Infect Immun (1986) 2.63
Optimized production and purification of Bacillus anthracis lethal factor. Protein Expr Purif (2000) 2.52
A Bacillus cereus cytolytic determinant, cereolysin AB, which comprises the phospholipase C and sphingomyelinase genes: nucleotide sequence and genetic linkage. J Bacteriol (1989) 2.33
Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection. Vaccine (1997) 2.31
Control of anthrax toxin gene expression by the transition state regulator abrB. J Bacteriol (2002) 2.27
The incompatibility between the PlcR- and AtxA-controlled regulons may have selected a nonsense mutation in Bacillus anthracis. Mol Microbiol (2001) 2.20
The plcR regulon is involved in the opportunistic properties of Bacillus thuringiensis and Bacillus cereus in mice and insects. Microbiology (2000) 2.09
Oligopeptide permease is required for expression of the Bacillus thuringiensis plcR regulon and for virulence. Mol Microbiol (2001) 1.95
Identification of a Bacillus thuringiensis gene that positively regulates transcription of the phosphatidylinositol-specific phospholipase C gene at the onset of the stationary phase. J Bacteriol (1996) 1.94
Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection. J Bacteriol (1999) 1.88
Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin. Infect Immun (2003) 1.81
Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus cereus. Eur J Biochem (1988) 1.80
Two-dimensional electrophoresis analysis of the extracellular proteome of Bacillus cereus reveals the importance of the PlcR regulon. Proteomics (2002) 1.69
Sequence analysis of three Bacillus cereus loci carrying PIcR-regulated genes encoding degradative enzymes and enterotoxin. Microbiology (1999) 1.58
Identification of self-transmissible plasmids in four Bacillus thuringiensis subspecies. J Bacteriol (1987) 1.51
An evolutionary link between sporulation and prophage induction in the structure of a repressor:anti-repressor complex. J Mol Biol (1998) 1.47
Physical analysis of Tn10- and IS10-promoted transpositions and rearrangements. Genetics (1987) 1.40
Regulation of toxin and virulence gene transcription in Bacillus thuringiensis. Int J Med Microbiol (2000) 1.37
Characterisation of a repressor gene (xre) and a temperature-sensitive allele from the Bacillus subtilis prophage, PBSX. Gene (1990) 1.32
Complete nucleotide sequence of Tn10. J Bacteriol (2000) 1.23
Anaerobic induction of Bacillus anthracis hemolytic activity. Biochem Biophys Res Commun (2003) 1.14
Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies. J Immunol Methods (1992) 0.99
Cooperative, synergistic and antagonistic haemolytic interactions between haemolysin BL, phosphatidylcholine phospholipase C and sphingomyelinase from Bacillus cereus. Microbiology (2000) 0.91
[Nucleotide sequence of phospholipase C and sphingomyelinase genes from Bacillus cereus BKM-B164]. Bioorg Khim (1993) 0.86
JaMBW 1.1: Java-based Molecular Biologists' Workbench. Comput Appl Biosci (1997) 0.84
Utilization of phosphatidylcholine and production of diradylglycerol as a consequence of sphingomyelin synthesis. Biochem J (1998) 0.84
Transformation of microorganisms with the plasmid vector with the replicon from pAC1 from Acetobacter pasteurianus. Biochem Biophys Res Commun (1995) 0.82
An estimate of large-scale sequencing accuracy. EMBO Rep (2000) 0.80
Purification and characterization of neutral sphingomyelinase from Helicobacter pylori. Biochemistry (2000) 0.79
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science (1998) 10.53
Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A (1982) 10.36
Crystal structure of the anthrax toxin protective antigen. Nature (1997) 6.63
Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc Natl Acad Sci U S A (1992) 4.91
Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem (1992) 4.87
Crystal structure of the anthrax lethal factor. Nature (2001) 3.75
Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa. Infect Immun (1976) 3.45
Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene (1988) 3.10
Production and purification of anthrax toxin. Methods Enzymol (1988) 3.04
Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun (1995) 2.87
Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 2.86
Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect Immun (1984) 2.70
Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun (1988) 2.69
Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol Microbiol (1994) 2.65
Immunization studies with attenuated strains of Bacillus anthracis. Infect Immun (1986) 2.63
Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin. Infect Immun (1988) 2.63
Optimized production and purification of Bacillus anthracis lethal factor. Protein Expr Purif (2000) 2.52
Cloning and characterization of a gene whose product is a trans-activator of anthrax toxin synthesis. J Bacteriol (1993) 2.46
Cloning of the protective antigen gene of Bacillus anthracis. Cell (1983) 2.31
A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo. J Biol Chem (1989) 2.31
Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J Biol Chem (1993) 2.23
Characterization of the subunit structure of the ribonucleic acid genome of influenza virus. J Virol (1971) 2.22
Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies. Microbiology (1996) 2.16
Association of diphtheria toxin with Vero cells. Demonstration of a receptor. J Biol Chem (1978) 2.13
Inhibition of protein synthesis by Shiga toxin: activation of the toxin and inhibition of peptide elongation. FEBS Lett (1980) 2.05
Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect Immun (1993) 1.97
Receptor-mediated internalization and degradation of diphtheria toxin by monkey kidney cells. J Biol Chem (1979) 1.94
Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and -resistant cells. J Biol Chem (1989) 1.93
Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): a calmodulin-dependent adenylate cyclase. Gene (1988) 1.90
Transcriptional regulation of the protective antigen gene of Bacillus anthracis. Infect Immun (1989) 1.86
Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells. Infect Immun (1994) 1.84
Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin. Infect Immun (1990) 1.78
Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis. J Ind Microbiol Biotechnol (2002) 1.75
Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect Immun (2001) 1.75
Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin. J Biol Chem (2001) 1.73
Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells. J Biol Chem (1992) 1.71
Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin. Infect Immun (1999) 1.68
Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies. Mol Med (1998) 1.64
Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med Microbiol Immunol (1988) 1.61
Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases. Infect Immun (1994) 1.61
Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells. Infect Immun (1999) 1.58
The pore-forming toxin proaerolysin is activated by furin. J Biol Chem (1998) 1.54
Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis. J Biol Chem (1991) 1.52
Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis. Gene (1986) 1.51
Purification and characterization of adenylyl cyclase from Bacillus anthracis. Methods Enzymol (1991) 1.48
The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor. J Biol Chem (1994) 1.47
Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin. Cancer Res (2000) 1.43
The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity. J Biol Chem (1991) 1.41
Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J Biol Chem (1989) 1.39
Proteasome activity is required for anthrax lethal toxin to kill macrophages. Infect Immun (1999) 1.32
Selective export of MHC class I molecules from the ER after their dissociation from TAP. Immunity (2000) 1.31
Calcium is required for the expression of anthrax lethal toxin activity in the macrophagelike cell line J774A.1. Infect Immun (1989) 1.31
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc Natl Acad Sci U S A (2001) 1.28
Clostridium septicum alpha toxin uses glycosylphosphatidylinositol-anchored protein receptors. J Biol Chem (1999) 1.26
The exotoxin P. aeruginosa: a proenzyme having an unusual mode of activation. Biochem Biophys Res Commun (1978) 1.25
Anemia of a mild viral infection: the measles vaccine as a model. Pediatrics (1989) 1.21
Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. Vaccine (1999) 1.20
Functional characterization of protease-treated Bacillus anthracis protective antigen. J Biol Chem (1992) 1.20
A role for PACE4 in the proteolytic activation of anthrax toxin protective antigen. Infect Immun (1997) 1.13
Cytotoxic effects of a chimeric protein consisting of tetanus toxin light chain and anthrax toxin lethal factor in non-neuronal cells. J Biol Chem (1994) 1.10
Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis. Infect Immun (1998) 1.10
Effects of lectins on the interaction of diphtheria toxin with mammalian cells. Exp Cell Res (1979) 1.09
Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein. Proc Natl Acad Sci U S A (1997) 1.09
Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids. Infect Immun (1981) 1.08
Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1. FEBS Lett (1995) 1.07
Clostridium septicum alpha-toxin is proteolytically activated by furin. Infect Immun (1997) 1.04
Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils. Proc Soc Exp Biol Med (1985) 1.04
Structure-function analysis of Bacillus anthracis edema factor by using monoclonal antibodies. Biochem Biophys Res Commun (1994) 1.04
Furin regulates both the activation of Pseudomonas exotoxin A and the Quantity of the toxin receptor expressed on target cells. Infect Immun (1996) 1.02
Platelet-activating factor acetylhydrolase in term and preterm human milk: a preliminary report. J Pediatr Gastroenterol Nutr (1994) 0.98
A dominant-negative therapy for anthrax. Nat Med (2001) 0.95
Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors. Ann Oncol (2004) 0.93
Permanent hypertension after renal homotransplantation in man. Clin Sci Mol Med (1975) 0.92
Evaluation of Pseudomonas aeruginosa toxin A in experimental rat burn wound sepsis. Infect Immun (1979) 0.92
Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy. Ann Oncol (2003) 0.91
Delivery of antigens to the MHC class I pathway using bacterial toxins. Hum Immunol (1997) 0.89
[Acquirement of the Spanish vocabulary among rural and urban students of the 9th region]. Rev Chil Pediatr (1992) 0.88
Comparison of the 3' termini of discrete segments of the double-stranded ribonucleic acid genomes of cytoplasmic polyhedrosis virus, wound tumor virus, and reovirus. J Virol (1972) 0.88
[A new site-specific endodeoxyribonuclease EcoHI]. Mol Gen Mikrobiol Virusol (1990) 0.87
Limbal conjunctival autograft in a subacute alkaline corneal burn. Cornea (1994) 0.86
Crystallization of the protective antigen protein of Bacillus anthracis. J Biol Chem (1985) 0.85
In vitro processing of anthrax toxin protective antigen by recombinant PC1 (SPC3) and bovine intermediate lobe secretory vesicle membranes. Arch Biochem Biophys (1995) 0.85
[Changes in the hemogram and in the laboratory parameters indicative of iron metabolism in mild viral infections]. Sangre (Barc) (1993) 0.84
Effect of ammonium chloride on receptor-mediated uptake of diphtheria toxin by Vero cells. Exp Cell Res (1981) 0.84
Separation of three exotoxic factors of Bacillus anthracis by sequential immunosorbent chromatography. Toxicon (1988) 0.81
Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein. Vaccine (2001) 0.80
Selective export of MHC class I molecules from the ER after their dissociation from TAP. Immunity (2001) 0.77
Influence of carcass weight on instrumental and sensory lamb meat quality in intensive production systems. Meat Sci (1996) 0.76
Favourable impact of regular swimming in young people with haemophilia: experience derived from 'Desafio del Caribe' project. Haemophilia (2014) 0.76
[Thyroid profile in normal pregnancy]. Rev Med Chil (1993) 0.75
[Colonoscopic diagnosis]. Rev Gastroenterol Peru (1994) 0.75
[Clinical manifestations and leukocyte response induced by measles vaccination]. Rev Chil Pediatr (1988) 0.75
[Bacteriologic and parasitologic survey of hospital food handlers (author's transl)]. Rev Med Chil (1980) 0.75
[Duodenitis]. G E N (1978) 0.75
[Motivation for studying health careers (author's transl)]. Rev Med Chil (1980) 0.75
[Laparoscopy in obstructive jaundice. Our experience]. Rev Esp Enferm Apar Dig (1977) 0.75
[Leiomyosarcoma of the duodenal bulb. Presentation of a case with digestive hemorrhage and abdominal mass]. Rev Esp Enferm Dig (1991) 0.75
[Unusual complications of laparoscopy]. Rev Esp Enferm Apar Dig (1977) 0.75
[Ultrasonics in the diagnosis of choledocholithiasis]. Rev Med Chil (1989) 0.75